Skip to main content

Operations

By Jessica Hagen | 02:15 pm | August 27, 2025
The ring maker will open a manufacturing facility in Fort Worth, Texas, to support its largest enterprise customer.
By HIMSS TV | 10:44 am | August 27, 2025
Keck Medicine of USC data scientist Yesha Patel says that the ideal AI tool implementation strategy depends on what the organization is trying to solve, whether there is in-house expertise, the long-term vision and other factors.
By HIMSS TV | 10:26 am | August 26, 2025
Roger Neal, VP and COO at DRH Health, says that due to the complexities of the healthcare industry, "our goal right now needs to be to get neutral" rather than getting ahead of cyberthreat challenges.
By HIMSS TV | 10:24 am | August 25, 2025
Columbia University Associate Dean of AI Stephen Ferrara, who is past president of the American Association of Nurse Practitioners, says getting buy-in requires building AI literacy and educating nurses on "what AI can do, and what it can't".
By Anthony Vecchione | 12:10 pm | August 22, 2025
Inbox Health's patient billing team will be responsible for overseeing inbound calls, chat and email for CHE Behavioral Health Services' patient queries.
By HIMSS TV | 11:00 am | August 22, 2025
Wooster Community Hospital Health System CIO Eric Gasser, RN, discusses ways that IT leaders can more effectively work with nurses and help solve major challenges.
By HIMSS TV | 09:36 am | August 21, 2025
Sukrti Nagpal, deputy chief medical officer of virtual care provider Doccla, and Yosef Safi Harb, founder and CEO of health monitoring company Happitech, discuss how the companies are working together to help patients at home and physicians.
By HIMSS TV | 10:30 am | August 20, 2025
Dr. Deepti Pandita, UC Irvine Health CMIO & VP of Clinical Informatics, says that "if you don't have governance, anything can fall apart," and discusses the need to engage a diverse multi-stakeholder group to vet every AI project that is deployed.
By Anthony Vecchione | 02:58 pm | August 15, 2025
The financing comes on top of the company's $900 million annual research and development investment in the U.S.
By Jessica Hagen | 12:40 pm | August 15, 2025
The company's CEO defended its feature as a wellness tool under the 21st Century Cures Act, combating the FDA’s claim that it qualifies as a regulated medical device.